Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Bilcare Ltd

Your Vote -

Buy

80.00%

Hold

10.00%

Sell

10.00%

80.00%

10 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Bilcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Bilcare Ltd. - Unaudited Financials Results (Standalone And Consolidated) For The Quarter And Nine Months Ended 31St December

    13 Feb 2025, 9:07PM Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months Ended 31st December 2024 together with the Limited Review Re
  • Bilcare posts Q3 net profit of Rs 1.80 cr

    13 Feb 2025, 9:00PM The company reported standalone net profit during the quarter stood at Rs 1.80 crore compared to net loss of Rs 1.55 crore in the previous year quarte
  • Bilcare Ltd. - Integrated Filing (Financial)

    13 Feb 2025, 9:00PM Integrated Filing (Financial) - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months Ended 31st December 2024 tog
  • Bilcare Ltd. - Unaudited Financial Results (Standalone And Consolidated) For The Quarter & Nine Months Ended 31St December 20

    13 Feb 2025, 8:22PM Unqualified Financials Results (Standalone and Consolidated) for the Quarter and Nine Months Ended 31st December 2024 together with the Limited Review
  • Bilcare Ltd. - Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results (Standalone And Consolidated)

    13 Feb 2025, 8:12PM Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) For The Quarter & Nine Months Ended 31st December 2024 Together Wi
  • Bilcare Ltd. - Board Meeting Intimation for For Considering And Approving The Un-Audited Financial Results For The Quarter An

    6 Feb 2025, 7:22PM BILCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approv
  • Bilcare Ltd. has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024

    21 Jan 2025, 9:40PM As of December 2024, 30.01% is owned by Indian Promoters and 69.99% by Public. <p align=justify> Top three Promoters holding highest number of shares
  • Bilcare Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    20 Jan 2025, 4:49PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2024.

Key fundamentals

Evaluate the intrinsic value of Bilcare Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 425.1541 417.9242 733.3333 739.138 767.7305
Liabilities 425.1541 417.9242 733.3333 739.138 767.7305
Equity 23.5452 23.5452 23.5452 23.5452 23.5452
Gross Profit -9.1118 -7.1391 36.74 25.1492 -7.5979
Net Profit 5.3412 390.7863 -17.7848 1.7834 -102.3235
Cash From Operating Activities 97.6332 397.427 46.2908 -0.413 71.1238
NPM(%) 30.34 2794.6 -4.13 0.58 -48.32
Revenue 17.6035 13.9836 429.7856 304.162 211.7511
Expenses 26.7153 21.1227 393.0456 279.0128 219.349
ROE(%) 1.12 82.14 -3.73 0.37 -21.5

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Bilcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Mewar Polytex Ltd 71.00 0.00 7.31 21.34 89.35 0.00
Panther Industrial Products Ltd 71.66 5.00 0.00 9.25 6.90 0.00
Midland Polymers Ltd 23.90 -4.97 0.00 4.42 -68.33 0.00
Huhtamaki India Ltd 187.45 0.03 16.04 499.23 582.41 1.07

Company Info

The company has been promoted by Mr. Mohan H. Bhandari and his two brothers Mr. Kiran H. Bhandari and Mr. Prakash H. Bhandari as Bhandari Paper Products (P) Ltd. on 1st July. 1987 and subsequently the assets and liabilities of a partnership concern named as New India Packaging Company were taken over by the company in 1987. Subsequently the name was changed to Bhandari Industries Private Limited and converted into Public Limited Company by passing a special resolution on 24/10/1994 and a fresh certificate of incorporation was obtained on 27/10/1994 from Registrar of companies Maharashtra, Bombay. The Managing Director Mr. Mohan Bhandari, is in the business for last 12 years and the wholetime Directors. Mr. Kiran Bhandari and Mr. Prakash Bhandari are associated with the Company since inception in 1987. The products of the Company have a good demand in the market and are well received and accepted. The company has been in the manufacture of Paper Tubes and Paper Containers for yarn industry and defence respectively. The company has been supplying laminated paper containers used for packing of ammunition to the Ministry of Defence till 1991. The shift in technology in the defence industry and the reduction in the Government's spending resulted in big reduction of defence orders. The company initiated necessary steps and changed the product mix with a thrust on paper tubes for synthetic textileayarn industry. 2003 - Issue and allotment of bonus shares in the ratio of 2 (two) equity shares for every 1 equity share held . -Bilcare Ltd has informed that at its meeting held on December 24, 2003 approved the allotment of 65,65,200 equity shares of Rs 10/- as fully paid bonus shares in the proportion of 2 equity shares for every 1 fully paid equity share held by them. 2005 -Bilcare inaugurates first-of-its-kind 'Clinical Services' facility in India 2009 - Bilcare Ltd has informed that Dr. Arthur J Carty and Prof. Dr. Bhojraj Suresh have been appointed as Directors on the Board of Directors of the Company with effect from July 09, 2009. 2010 -"Bilcare ushers into successful execution of nonClonablelD technology worldwide". -"Bilcare AG successfully completes the acquisition of INEOS' Global Films Business". 2012 -Bilcare signed a definitive agreement with United Drug plc, a Euro 1.7 billion revenue leading international provider of healthcare services". -Pharma packaging solution provider Bilcare Ltd said that United Drug plc has completed the USD 61 million acquisition of its US and UK-based Global Clinical Supplies (GCS) businesses. 2014 -CS Pawan G. Chandak has been appointed as Director of the company. -The company got Frost & Sullivan Global 2014 Award. -The company also got CII Industrial Innovation Award. 2015 -Bilcare has been recognized as Admired 100 Brands & Leaders of Asia-2014-15 by VWP World Brands. 2016 -Bilcare GCS receiving ABP News Healthcare award 2015 for best Clinical Trial Services.

The company has been promoted by Mr. Mohan H. Bhandari and his two brothers Mr. Kiran H. Bhandari and Mr. Prakash H. Bhandari as Bhandari Paper Products (P) Ltd. on 1st July. 1987 and subsequently the assets and liabilities of a partnership concern named as New India Packaging Company were taken over by the company in 1987. Subsequently the name was changed to Bhandari Industries Private Limited and converted into Public Limited Company by passing a special resolution on 24/10/1994 and a fresh certificate of incorporation was obtained on 27/10/1994 from Registrar of companies Maharashtra, Bombay. The Managing Director Mr. Mohan Bhandari, is in the business for last 12 years and the wholetime Directors. Mr. Kiran Bhandari and Mr. Prakash Bhandari are associated with the Company since inception in 1987. The products of the Company have a good demand in the market and are well received and accepted. The company has been in the manufacture of Paper Tubes and Paper Containers for yarn industry and defence respectively. The company has been supplying laminated paper containers used for packing of ammunition to the Ministry of Defence till 1991. The shift in technology in the defence industry and the reduction in the Government's spending resulted in big reduction of defence orders. The company initiated necessary steps and changed the product mix with a thrust on paper tubes for synthetic textileayarn industry. 2003 - Issue and allotment of bonus shares in the ratio of 2 (two) equity shares for every 1 equity share held . -Bilcare Ltd has informed that at its meeting held on December 24, 2003 approved the allotment of 65,65,200 equity shares of Rs 10/- as fully paid bonus shares in the proportion of 2 equity shares for every 1 fully paid equity share held by them. 2005 -Bilcare inaugurates first-of-its-kind 'Clinical Services' facility in India 2009 - Bilcare Ltd has informed that Dr. Arthur J Carty and Prof. Dr. Bhojraj Suresh have been appointed as Directors on the Board of Directors of the Company with effect from July 09, 2009. 2010 -"Bilcare ushers into successful execution of nonClonablelD technology worldwide". -"Bilcare AG successfully completes the acquisition of INEOS' Global Films Business". 2012 -Bilcare signed a definitive agreement with United Drug plc, a Euro 1.7 billion revenue leading international provider of healthcare services". -Pharma packaging solution provider Bilcare Ltd said that United Drug plc has completed the USD 61 million acquisition of its US and UK-based Global Clinical Supplies (GCS) businesses. 2014 -CS Pawan G. Chandak has been appointed as Director of the company. -The company got Frost & Sullivan Global 2014 Award. -The company also got CII Industrial Innovation Award. 2015 -Bilcare has been recognized as Admired 100 Brands & Leaders of Asia-2014-15 by VWP World Brands. 2016 -Bilcare GCS receiving ABP News Healthcare award 2015 for best Clinical Trial Services.

Read More

Parent Organisation

Bilcare Ltd.

Founded

01/07/1987

Managing Director

Mr.Shreyans Bhandari

NSE Symbol

FAQ

The current price of Bilcare Ltd is

The 52-week high for Bilcare Ltd is

The market capitalization of Bilcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Bilcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Bilcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Bilcare Ltd shares.

The CEO of Bilcare Ltd is Mr.Shreyans Bhandari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT